Where does Actinium Phamaceuticals, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Actinium Phamaceuticals, Inc. ranks #16,549 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Actinium Phamaceuticals, Inc. hold?

Actinium Phamaceuticals, Inc. holds 17 US utility patents granted between 2017 and 2025, spanning 14 technology areas.

What is Actinium Phamaceuticals, Inc.'s Innovation Score?

Actinium Phamaceuticals, Inc. has an Innovation Score of 53.4 out of 100 (top 9% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Actinium Phamaceuticals, Inc. focus on?

Actinium Phamaceuticals, Inc.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 17 patents, ranking #1,331 of 7,163 assignees active in that subclass. Grants appear in 14 CPC subclasses total.

Is Actinium Phamaceuticals, Inc.'s patent grant rate increasing or decreasing?

Actinium Phamaceuticals, Inc.'s recent grant velocity is +200% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Actinium Phamaceuticals, Inc.'s patents?

Actinium Phamaceuticals, Inc.'s patents average 17.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Actinium Phamaceuticals, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Actinium Phamaceuticals, Inc.

USPTO PatentsView assignee record - 17 granted patents across 14 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Actinium ranks #16,549 of 49,997 tracked US assignees by granted-patent volume, with 17 patents across 14 technology areas.

#16,549
of 49,997 US assignees by volume: Top 9%
by Innovation Score (53.4/100): 17.0
avg claims per patent: +200%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R16549 · US Corporation #16,549 · 17 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 17 grants
MID-PACK #16,549/49,997
PHOTO-FINISH Accel Performance…
CPC-FOCUS A61K · 14 areas
INNOV-PAR 53.4/100
CLAIMS-RICH 17.0 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +200% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Accel Performance Group LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Actinium’s 53.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.0 pts (19%) Velocity 20.0 pts (37%) Breadth 13.2 pts (25%) Claim depth 10.2 pts (19%)

Qualcomm Incorporated · highest

85
Actinium Phamaceutic… · this assignee

53
3D Lighting… · lowest

7

What this shows Actinium's Innovation Score is 53.4/100 (top 9% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Actinium?

Each dot is one of Actinium’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Actinium’s own 17.0 claims/patent is at or below the 18.3 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Actinium vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Actinium's grants concentrate

Actinium Phamaceuticals, Inc. is a focused PatentsView assignee: 14 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2024 (6 grants) versus a trough of 1 in 2019. By volume, Actinium sits between Accel Performance Group LLC and AetherPal Inc..

Actinium's three-year grant acceleration

Actinium Phamaceuticals, Inc. shows 11 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Accel Performance…

17
Acceptto

17
Accusoft

17
Acmeda Pty

17
Advanced Cooling…

17
Advanced Testing

17
Aerosol Dynamics

17
Aetherpal

17
Actinium Phamaceu… ◀

17

What this shows Actinium holds 17 patents at rank #16,580, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Actinium

By rank, the assignees closest to #16,580 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Actinium's primary technology class.

Actinium's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

53 Top 9% higher than 91% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Actinium Phamaceuticals, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	3	17.6%
2019	1	5.9%
2020	1	5.9%
2022	4	23.5%
2023	1	5.9%
2024	6	35.3%
2025partial year	1	5.9%

Which technologies does Actinium Phamaceuticals, Inc. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 17

C07K - Peptides 14

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 11

C07D - Heterocyclic Compounds 2

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 2

G21G - Conversion OF Chemical ELEMENTS; Radioactive Sources 2

C22B - Production AND Refining OF Metals ; Pretreatment OF RAW Materials 2

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 2

B01D - Separation 2

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 1

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

A61B - DIAGNOSIS; SURGERY; Identification 1

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

Top 14 of 14 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Actinium Phamaceuticals, Inc.'s patent record in context - here's where to go next.

Actinium Phamaceuticals, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #16,549 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Actinium Phamaceuticals, Inc. against Accel Performance Group LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 53.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.